Oakley Capital IV, managed by Oakley Capital Investments Limited (LSE:OCI) agreed to acquire WindStar Medical GmbH from NCG - NuCom Group SE and others for an enterprise value of €280 million on October 22, 2020. As a part of transaction, NCG - NuCom Group SE will sell 92% stake in WindStar Medical GmbH and other minority shareholders will sell remaining stake. Pemberton Capital Advisors LLP is supporting Oakley Capital and WindStar Medical with the provision of debt financing via its Mid-Market Debt Strategy. This transaction is a platform acquisition. The transaction is subject to the approval of relevant antitrust authorities. The transaction is expected to close in fourth Quarter 2020. As of November 5, 2020, transaction is expected to close in November 2020. Gillian Martin of Liberum Capital Limited acted as financial advisor to Oakley. Benjamin Leyendecker, Alexander Längfeld, Oded Schein and Daniel Hiemer of Kirkland & Ellis LLP acted as legal advisor to Oakley Capital. Oliver Schiller, Ralph Miller, Ekaterina Ksoll and Tim Schwerdtfeger of Rothschild & Co SCA and FERBER & CO. GmbH acted as financial advisors to Oakley Capital. Martin Erhardt, Thomas Kleinheisterkamp, Alexander Rinne and Michael Pujol of Milbank LLP acted as legal advisor to NCG. Oakley Capital IV, managed by Oakley Capital Investments Limited (LSE:OCI) completed the acquisition of WindStar Medical GmbH from NCG - NuCom Group SE and others on December 1, 2020. The approval of the relevant antitrust authorities was obtained on December 1, 2020.